| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/16/2003 | CN1410080A Formulation of capsule medicine for treating gastropathy and its preparation technology |
| 04/16/2003 | CN1410078A Medicine for treating stomach disease and its preparation method |
| 04/16/2003 | CN1410074A Application of fur seal oil in preparation of medicine for treating acute liver damage |
| 04/16/2003 | CN1410073A Application of fur seal oil in preparation of medicine for treating fatty liver |
| 04/16/2003 | CN1410062A Sodium rebeilazole for injection use |
| 04/16/2003 | CN1410059A Treating method and medicine kit containing somatotrophic hormone secretory agent |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105568C Chinese medicine for curing stomatopathy |
| 04/16/2003 | CN1105566C Chinese patent medicine for treating gastrosis |
| 04/16/2003 | CN1105506C 碳水化合物混合物 Carbohydrate blend |
| 04/15/2003 | US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 04/15/2003 | US6548522 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide |
| 04/15/2003 | US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/15/2003 | US6548518 As well as 5-HT3 antagonists and 5-HT4 agonists; for preventing or managing gastro-esophageal reflux disease and/or emesis |
| 04/15/2003 | US6548514 Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders |
| 04/15/2003 | US6548504 Compounds |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548501 Composition and methods for stimulating gastrointestinal motility |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548498 Substituted indan derivatives |
| 04/15/2003 | US6548495 Dihydro-benzo [B] [1,4] diazepin-2-one derivatives |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | US6548295 Complex of lipo-viro-particles, method of preparation and applications |
| 04/15/2003 | US6548284 Membrane-bound metalloprotease and soluble secreted form thereof |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/15/2003 | US6548062 Preferred for the treatment of prostate or pancreatic cancer. |
| 04/15/2003 | CA2070573C Derivatives of amide analogs of certain methano bridged quinolizines |
| 04/11/2003 | WO2002032899A1 Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 04/11/2003 | WO2002032898A2 Novel anticholinergics, method for the production thereof and use thereof as medicaments |
| 04/11/2003 | WO2002030934A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines |
| 04/11/2003 | CA2425685A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines |
| 04/10/2003 | WO2003029824A1 Method and agent for diagnosing and treating chronic inflammatory bowel diseases |
| 04/10/2003 | WO2003029465A1 HepNaDC GENE |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029433A2 Chimeric viral vectors for gene therapy |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029268A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 04/10/2003 | WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | WO2003029242A1 NF-λB INHIBITORS |
| 04/10/2003 | WO2003029215A1 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | WO2003029201A1 Methods and compositions for treating or preventing bacterial infection |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003029187A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003028763A1 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 04/10/2003 | WO2003028755A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 04/10/2003 | WO2003028754A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 04/10/2003 | WO2003028749A1 Matrix metalloprotease inhibitor |
| 04/10/2003 | WO2003028726A1 Quinoline derivatives as neuropeptide y antagonists |
| 04/10/2003 | WO2003028722A1 Treatment of hepatitis b virus infection with human monoclonal antibodies |
| 04/10/2003 | WO2003028716A1 Aqueous ecabet sodium solution preparation |
| 04/10/2003 | WO2003028715A2 Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis |
| 04/10/2003 | WO2003028712A2 Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases |
| 04/10/2003 | WO2003028699A1 Compositions used to alleviate xerostomia and to treat disorders associated with same |
| 04/10/2003 | WO2003028662A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 04/10/2003 | WO2003028537A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | WO2003028527A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/10/2003 | WO2003028473A1 Process for the fractionation of oilseed press cakes and meals |
| 04/10/2003 | WO2003017935A9 Human antibodies specific for interleukin 15 (il-15) |
| 04/10/2003 | WO2003014326A3 Isolation and mobilization of stem cells expressing vegfr-1 |
| 04/10/2003 | WO2003004493A8 Novel compounds, their preparation and use |
| 04/10/2003 | WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2003 | WO2002092064A3 Therapeutic method for inducing tolerance |
| 04/10/2003 | WO2002080982A9 Nucleic acid mucosal immunization |
| 04/10/2003 | WO2002080956A3 Use of compounds modulating rxr-ppar heterodimer activity as medicine for treating hepatitis c |
| 04/10/2003 | WO2002076472A3 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs |
| 04/10/2003 | WO2002074238A3 Water soluble and palatable complexes |
| 04/10/2003 | WO2002060423A3 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 04/10/2003 | WO2002059083A3 Novel compounds |
| 04/10/2003 | WO2002057460A3 Polynucleotides encoding human phosphatases |
| 04/10/2003 | WO2002030920A1 Benzimidazole compounds, process for producing the same and use thereof |
| 04/10/2003 | WO2002008396A3 Human proteases |
| 04/10/2003 | US20030069435 Prevention of neutrophil recruitment |
| 04/10/2003 | US20030069429 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 04/10/2003 | US20030069428 Pharmaceutically active isoindoline derivatives |
| 04/10/2003 | US20030069393 Compound for use in the treatment of cancer and prevention of infections |
| 04/10/2003 | US20030069290 Substituted-heteroaryl-7-aza[2.2.1] bycycloheptanes for the treatment of desease |
| 04/10/2003 | US20030069288 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 04/10/2003 | US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 04/10/2003 | US20030069280 S(-)rabeprazole compositions and methods |
| 04/10/2003 | US20030069279 Antimicrobial agent |
| 04/10/2003 | US20030069278 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | US20030069260 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 04/10/2003 | US20030069255 Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| 04/10/2003 | US20030069254 New arylsulfonyl derivatives with 5-HT6 receptor affinity |
| 04/10/2003 | US20030069248 Antiinflammatory agents; controlling cell cycle |
| 04/10/2003 | US20030069243 Novel substituted imidazole compounds |
| 04/10/2003 | US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents |
| 04/10/2003 | US20030069238 Anticancer agents; immunology diseases; antiallergens; antiinflammatory agents |
| 04/10/2003 | US20030069228 Capase inhibitors; antiinflammatory agents |
| 04/10/2003 | US20030069213 Oral preparation |
| 04/10/2003 | US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives |
| 04/10/2003 | US20030069183 Lyophilized HGF preparations |
| 04/10/2003 | US20030069169 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders |
| 04/10/2003 | US20030068429 Inulin products with improved nutritional properties |